Kym Anthony, CEO of Avivagen, was recently interviewed by Karoline Hunter, Head of TSX Company Services at the TMX group.

The interview covered the company story and gives a look ahead at the future of Avivagen’s OxC-BetaTM.

The interview also covers Immune Priming, its powerful anti-inflammatory effect, and its efficacy in improving Gut Health.